LEO CANCER CARE WAS FOUNDED WITH TWO POWERFUL GOALS
1. Improve the quality of Radiation Therapy delivery through upright positioning
2. Improve access to Radiation Therapy through the removal of gantries
Leo Cancer Care was founded with more than 100 years of Radiation Therapy experience by a team dedicated to challenging the norms in everything we do.
Patient’s lives influence us to find a better way, a better way to improve patient care and how a patient experiences it. A better way to increase the accessibility of cancer treatments for more patients in more places. We believe our technology is that better way. Our family of world class products can provide a streamlined and efficient treatment while making the patient feel in control and hopeful.
Originally founded in Australia, Leo Cancer Care has been built on research from across the globe showing the clinical benefits of upright patient positioning. Combining this with a shift from machine rotation to patient rotation, Leo Cancer Care is set to change the face of Radiation Therapy for good.
1. Improve the quality of Radiation Therapy delivery through upright positioning
2. Improve access to Radiation Therapy through the removal of gantries
Leo Cancer Care was founded with more than 100 years of Radiation Therapy experience by a team dedicated to challenging the norms in everything we do.
Patient’s lives influence us to find a better way, a better way to improve patient care and how a patient experiences it. A better way to increase the accessibility of cancer treatments for more patients in more places. We believe our technology is that better way. Our family of world class products can provide a streamlined and efficient treatment while making the patient feel in control and hopeful.
Originally founded in Australia, Leo Cancer Care has been built on research from across the globe showing the clinical benefits of upright patient positioning. Combining this with a shift from machine rotation to patient rotation, Leo Cancer Care is set to change the face of Radiation Therapy for good.
Location: United States
Employees: 11-50
Total raised: $130.3M
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | Yu Galaxy | yugalaxy.c... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 08.07.2026 | Series D | $65M | Yu Galaxy |
| 29.09.2025 | - | $40M | Catalio Ca... |
| 20.07.2021 | Series B | $25.3M | - |
Mentions in press and media 34
| Date | Title | Description |
| 17.09.2026 | Leo Cancer Care and Imperial College London Collaborate on Real-Time Tumour Tracking Research for Upright Radiotherapy | CRAWLEY, WEST SUSSEX, UNITED KINGDOM, September 17, 2026 /EINPresswire.com/ -- Leo Cancer Care today announced a research collaboration with Imperial College London, the LhARA collaboration and Imperial College Healthcare NHS Trust to inves... |
| 11.07.2026 | Floqer Secures $2M Pre-Seed, Unlocking Autonomous GTM Intelligence | Floqer, an AI innovator, just closed a $2 million pre-seed funding round. This financing fuels its autonomous customer knowledge base for go-to-market (GTM) teams. The platform unifies fragmented customer intelligence from over 100 sources.... |
| 09.07.2026 | Upright Revolution: Leo Cancer Care Secures $65M, Reshapes Oncology Landscape | Leo Cancer Care landed $65M Series D funding. The company revolutionizes cancer treatment. It uses an integrated upright platform for radiation therapy and imaging. Patients sit for treatment, enhancing comfort and consistency. This technol... |
| 08.07.2026 | Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform | Leo Cancer Care, the medical technology company working to reinvent how patients are imaged and treated by designing systems around the body’s natural upright position, today announced the close of an oversubscribed $65 million Series D fin... |
| 08.07.2026 | Leo Cancer Care Raises $65M in Series D Funding | Leo Cancer Care, a Middletown, WI- and London, UK-based medical technology company, raised $65M in Series D funding. The round was led by Yu Galaxy and with participation from Eventide Asset Management, alongside continued support from its ... |
| 08.07.2026 | Leo Cancer Care Raises $65 Million Series D To Scale Upright Cancer Care Platform | Leo Cancer Care announced the close of an oversubscribed $65 million Series D financing round. The round was led by Yu Galaxy, with new investor Eventide Asset Management joining alongside continued support from existing investors. Leo Canc... |
| 08.07.2026 | Leo Cancer Care Raises $65M Series D | MIDDLETON, WI, Leo Cancer Care today announced the close of an oversubscribed $65 million Series D financing. >> Click here for more funding data on Leo Cancer Care >> To export Leo Cancer Care funding data to PDF and Excel, cl... |
| 08.07.2026 | Leo Cancer Care secures $65M to advance upright radiotherapy system as company preps for IPO | Medical technology company Leo Cancer Care closed a $65 million series D financing round to scale its radiotherapy solution, which uses groundbreaking upright treatment technology. Silicon Valley’s Yu Galaxy led the round, which was backed ... |
| 08.07.2026 | Floqer Raises $2M in Pre-Seed Funding | Floqer, a Halifax, Nova Scotia, UK-based autonomous customer knowledge base for go-to-market teams, raised $2M in Pre-Seed funding. Backers included F7 Fund, N49P, Tidal Venture Partners, and Denis Yarats. The company intends to use the fun... |
| 20.06.2026 | Pope Leo XIV embraces paediatric patients at CNAO in Pavia | PAVIA, Italy, June 20, 2026 /PRNewswire/ -- The National Center for Oncological Hadrontherapy (CNAO) served as the first stop today during Pope Leo XIV's pastoral visit to the city of Pavia. His choice to begin his journey at this center re... |
Show more